Emmanuel S. Antonarakis, MD, is a board-certified medical oncologist and clinical-translational researcher specializing in genitourinary oncology. He is the Clark Endowed Professor of Medicine, Director of Genitourinary Oncology in the Division of Hematology, Oncology and Transplantation at the University of Minnesota Medical School, and Associate Director of Translational Research at the Masonic Cancer Center. His clinical practice focuses on the comprehensive care of genitourinary cancers, precision oncology, and clinical trials of novel therapies. Dr. Antonarakis’ research interests center on translational oncology, including predictive biomarkers, mechanisms of treatment resistance, and tumor and germline genomics with a focus on DNA-repair biology. His work is aimed at translating molecular discoveries into more personalized treatment strategies and advancing biomarker-driven therapeutic development. A nationally recognized physician-scientist, Dr. Antonarakis is an elected member of the American Society for Clinical Investigation and has received the SBUR Young Investigator Award and the University of Minnesota Dean’s Wall of Scholarship honor. He holds leadership roles with the NCCN Prostate Cancer Panel, ECOG-ACRIN, Alliance for Clinical Trials in Oncology, the NCI Prostate Cancer Task Force, and the Prostate Cancer Clinical Trials Consortium. He earned his medical degree from the University of Wales College of Medicine, completed his internal medicine residency at Johns Hopkins Bayview Medical Center, and pursued fellowship training in medical oncology at the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center and Johns Hopkins Hospital.
Professor
Medical School
1998 – 2003
Residency
2004 – 2007
Fellowship
2007 – 2010